Furthermore, in the FCH cohort, patients in the NOTCH1 high-expression group had significantly shorter OS than those in the low-expression group, which further verified the clinical significance of NOTCH1 as a poor prognostic marker for cervical cancer. The gene discussed is NOTCH1; the disease is cervical carcinoma.